comparemela.com

Latest Breaking News On - Cantheon capital - Page 1 : comparemela.com

Oxford Cannabinoid agrees GBP565,000 loan notes deal

Oxford Cannabinoid Technologies Holdings PLC - Oxford, England-based pharmaceutical company developing prescription cannabinoid medicines - Enters convertible loan note agreement with Cantheon.

Oxford Cannabinoid Technologies down after GBP1 2 million fundraise

Psychedelic drug firm raises €5 5m for trials

Alvarius, a biopharmaceutical start-up based in Dublin, has raised more than €5.5 million in the second round of funding for its psychedelic formula to treat addiction

RespireRx to transfer cannabinoid research program to Australian subsidiary ResolutionRx

RespireRx Pharmaceuticals (OTC:RSPI) shares rose on Wednesday morning after it announced that it has entered into agreements with its Australian subsidiary.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.